| Market Cap | ₹91,567Cr |
| ROE | 19.44% |
| P/E Ratio(TTM) | 18.22 |
| EPS(TTM) | 49.95 |
| P/B Ratio | 3.62 |
| Dividend Yield | 1.21% |
| Industry P/E | 31.55 |
| Book Value | 251.45 |
| Debt to Equity | 0.38 |
| Face Value | 1 |
| Managing Director | Dr. Sharvil P. Patel |
| Founded | 1995 |
| NSE Symbol | ZYDUSLIFE |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 37.23 | ||
| Cipla | NA (0.00%) | 24.16 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 19.18 | ||
| Lupin | NA (0.00%) | 21.74 |